C1GALT1 Seems to Promote In Vitro Disease Progression in Ovarian Cancer

No abstract is available for this paper.

• Publication year

  2017

• Venue

  International Journal of Gynecologic Cancer

• Publication date

  2017-02-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/IGC.0000000000000965PMID 28498248
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded.

  2016cited by this paper
• Clinical and urodynamic effects of baclofen in women with functional bladder outlet obstruction: Preliminary report

  2016cited by this paper
• OCT4 mediates FSH-induced epithelial-mesenchymal transition and invasion through the ERK1/2 signaling pathway in epithelial ovarian cancer.

  2015cited by this paper
• Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway

  2015cited by this paper
• Ovary and fimbrial stem cells: biology, niche and cancer origins

  2015cited by this paper
• Challenges in Antibody Development against Tn and Sialyl-Tn Antigens

  2015cited by this paper
• Cellular immunotherapy in ovarian cancer: Targeting the stem of recurrence.

  2015cited by this paper
• Glycosylation in cancer: mechanisms and clinical implications

  2015cited by this paper
• CD24 and Nanog identify stem cells signature of ovarian epithelium and cysts that may develop to ovarian cancer.

  2014cited by this paper
• β1, 4-N-acetylgalactosaminyltransferase III modulates cancer stemness through EGFR signaling pathway in colon cancer cells

  2014cited by this paper
• Mucinous Tumors of the Ovary: Current Thoughts on Diagnosis and Management

  2014cited by this paper
• Ovarian cancer

  2014cited by this paper
• Ovarian cancer stem cells: are they real and why are they important?

  2014cited by this paper
• C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2

  2014cited by this paper
• Global distribution pattern of histological subtypes of epithelial ovarian cancer: a database analysis and systematic review.

  2014cited by this paper
• Cancer statistics, 2014

  2014cited by this paper
• C1GALT1 Promotes Invasive Phenotypes of Hepatocellular Carcinoma Cells by Modulating Integrin β1 Glycosylation and Activity

  2014cited by this paper
• Ovarian surface epithelium at the junction area contains cancer-prone stem cell niche

  2013cited by this paper
• C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization.

  2013cited by this paper
• MUC20 overexpression predicts poor prognosis and enhances EGF-induced malignant phenotypes via activation of the EGFR-STAT3 pathway in endometrial cancer.

  2013cited by this paper
• Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients.

  2012cited by this paper
• Sialyl-Tn in Cancer: (How) Did We Miss the Target?

  2012cited by this paper
• Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.

  2011cited by this paper
• Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor.

  2011cited by this paper
• Cancer vaccines and carbohydrate epitopes.

  2011cited by this paper
• Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations.

  2011cited by this paper
• Mucin‐type O‐glycosylation – putting the pieces together

  2010cited by this paper
• CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells

  2010cited by this paper
• Recent insights into the biological roles of mucin-type O-glycosylation

  2009cited by this paper
• CD24 overexpression in cancer development and progression: a meta-analysis.

  2009cited by this paper
• Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice.

  2008cited by this paper
• Insulin-like growth factor binding protein-3 (IGFBP-3) acts as an invasion-metastasis suppressor in ovarian endometrioid carcinoma

  2008cited by this paper
• Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer.

  2005cited by this paper
• Defective angiogenesis and fatal embryonic hemorrhage in mice lacking core 1–derived O-glycans

  2004cited by this paper
• Characterization of the Oligosaccharides Associated with the Human Ovarian Tumor Marker CA125*

  2003cited by this paper
• Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study.

  2000cited by this paper
• Mucin carbohydrate antigens (T, Tn, and sialyl-Tn) in human ovarian carcinomas: relationship with histopathology and prognosis.

  1997cited by this paper
• Immunohistochemical study of mucin carbohydrates and core proteins in human ovarian tumors.

  1994cited by this paper
• Molecular genetics for the clinician

  1993cited by this paper
• Cancer statistics

  1989cited by this paper

• The O-glycosyltransferase C1GALT1 promotes EWSR1::FLI1 expression and is a therapeutic target for Ewing sarcoma

  2025cites this paper
• Inhibition of the galactosyltransferase C1GALT1 reduces osteosarcoma cell proliferation by interfering with ERK signaling and cell cycle progression

  2024cites this paper
• High core 1β1,3-galactosyltransferase 1 expression is associated with poor prognosis and promotes cellular radioresistance in lung adenocarcinoma

  2024cites this paper
• Glycan diversity in ovarian cancer: Unraveling the immune interplay and therapeutic prospects

  2024cites this paper
• Update on the role of C1GALT1 in cancer

  2022cites this paper
• Next-Generation Sequencing analysis discloses genes implicated in equine endometrosis that may lead to tumorigenesis.

  2022cites this paper
• Emerging Roles of the Unique Molecular Chaperone Cosmc in the Regulation of Health and Disease

  2022cites this paper
• Down-Regulation of C1GALT1 Enhances the Progression of Cholangiocarcinoma through Activation of AKT/ERK Signaling Pathways

  2022cites this paper
• A novel mechanism for C1GALT1 in the regulation of gastric cancer progression

  2021cites this paper
• Mucin-Type O-Glycans: Biosynthesis and Functions

  2021cites this paper
• C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin αv

  2021cites this paper
• The evolving role of MUC16 (CA125) in the transformation of ovarian cells and the progression of neoplasia.

  2021cites this paper
• C1GALT1 in health and disease

  2021cites this paper
• C1GALT1, Negatively Regulated by miR-181d-5p, Promotes Tumor Progression via Upregulating RAC1 in Lung Adenocarcinoma

  2021cites this paper
• A Novel Glycosyltransferase-Related Gene Signature for Overall Survival Prediction in Patients with Ovarian Cancer

  2021cites this paper
• Anti‐C1GALT1 Autoantibody Is a Novel Prognostic Biomarker for Patients With Head and Neck Cancer

  2020cites this paper
• A Systematic Review on the Implications of O-linked Glycan Branching and Truncating Enzymes on Cancer Progression and Metastasis

  2020cites this paper
• Mucins and Truncated O-Glycans Unveil Phenotypic Discrepancies between Serous Ovarian Cancer Cell Lines and Primary Tumours

  2018cites this paper
• Clinic implication of MUC1 O-glycosylation and C1GALT1 in esophagus squamous cell carcinoma

  2018cites this paper